Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.

Okazaki S, Morimoto T, Kamatani Y, Kamimura T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Washida K, Saito S, Takahashi A, Hirata M, Matsuda K, Mochizuki H, Chong M, Paré G, O'Donnell M, Ago T, Hata J, Ninomiya T, Dichgans M, Debette S, Kubo M, Koizumi A, Ihara M.

Circulation. 2019 Jan 8;139(2):295-298. doi: 10.1161/CIRCULATIONAHA.118.038439. No abstract available.

PMID:
30615506
2.

Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.

Zhang T, Guo C, Liao X, Xia J, Wang X, Deng J, Yan J.

Environ Health Prev Med. 2017 Apr 24;22(1):41. doi: 10.1186/s12199-017-0649-0.

3.

Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.

Liao X, Deng J, Dai W, Zhang T, Yan J.

Environ Health Prev Med. 2017 Nov 2;22(1):75. doi: 10.1186/s12199-017-0680-1. Review.

4.

RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.

Wang Y, Mambiya M, Li Q, Yang L, Jia H, Han Y, Liu W.

J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2259-2270. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.013. Epub 2018 May 8.

PMID:
29752070
5.

RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.

Matsuda Y, Mineharu Y, Kimura M, Takagi Y, Kobayashi H, Hitomi T, Harada KH, Uchihashi Y, Funaki T, Miyamoto S, Koizumi A.

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1841-1847. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.019. Epub 2017 May 11.

PMID:
28506590
6.

Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A.

PLoS One. 2011;6(7):e22542. doi: 10.1371/journal.pone.0022542. Epub 2011 Jul 20.

7.

Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.

Morimoto T, Mineharu Y, Ono K, Nakatochi M, Ichihara S, Kabata R, Takagi Y, Cao Y, Zhao L, Kobayashi H, Harada KH, Takenaka K, Funaki T, Yokota M, Matsubara T, Yamamoto K, Izawa H, Kimura T, Miyamoto S, Koizumi A.

PLoS One. 2017 Apr 17;12(4):e0175649. doi: 10.1371/journal.pone.0175649. eCollection 2017.

8.

Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.

Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, Goo HW, Ko TS, Yoo HW.

J Neurosurg. 2016 May;124(5):1221-7. doi: 10.3171/2015.4.JNS142900. Epub 2015 Oct 2.

PMID:
26430847
9.

Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.

Liu Y, Wu X, Fan Z, Cheng J, Zhong L, Lin Y, Qu X.

Clin Neurol Neurosurg. 2018 May;168:163-166. doi: 10.1016/j.clineuro.2018.01.034. Epub 2018 Feb 2.

PMID:
29567577
10.

RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.

Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, Yu L, Lu C, Liu F, Zhou J, Zhang X, Zhao J.

J Neurosurg. 2017 Apr;126(4):1106-1113. doi: 10.3171/2016.2.JNS152173. Epub 2016 Apr 29.

PMID:
27128593
11.

Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.

Cao Y, Kobayashi H, Morimoto T, Kabata R, Harada KH, Koizumi A.

Environ Health Prev Med. 2016 Sep;21(5):387-390. doi: 10.1007/s12199-016-0549-8. Epub 2016 Jun 30.

12.

Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.

Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A.

Neurol Med Chir (Tokyo). 2012;52(5):299-303.

13.

The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.

Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, Taura D, Sone M, Asaka I, Ameku T, Watanabe A, Kasahara T, Sudo T, Shiota F, Hashikata H, Takagi Y, Morito D, Miyamoto S, Nakao K, Koizumi A.

Biochem Biophys Res Commun. 2013 Oct 4;439(4):419-26. doi: 10.1016/j.bbrc.2013.08.067. Epub 2013 Aug 27.

PMID:
23994138
14.

Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.

Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, Song D, Zhang J, Guan M, Gu Y.

PLoS One. 2012;7(10):e48179. doi: 10.1371/journal.pone.0048179. Epub 2012 Oct 23.

15.

Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.

Chong PF, Ogata R, Kobayashi H, Koizumi A, Kira R.

Brain Dev. 2015 Sep;37(8):822-4. doi: 10.1016/j.braindev.2014.12.006. Epub 2014 Dec 26.

PMID:
25547042
16.

Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.

Morimoto T, Mineharu Y, Kobayashi H, Harada KH, Funaki T, Takagi Y, Sakai N, Miyamoto S, Koizumi A.

J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2632-2636. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.004. Epub 2016 Jul 28.

PMID:
27476341
17.

The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.

Zhang Q, Liu Y, Yu L, Duan R, Ma Y, Ge P, Zhang D, Zhang Y, Wang R, Wang S, Zhao Y, Cao Y, Liu X, Deng X, Zhao J, Zhang X.

World Neurosurg. 2017 Mar;99:701-708.e1. doi: 10.1016/j.wneu.2016.12.119. Epub 2017 Jan 5. Review.

PMID:
28063898
18.

A new horizon of moyamoya disease and associated health risks explored through RNF213.

Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S.

Environ Health Prev Med. 2016 Mar;21(2):55-70. doi: 10.1007/s12199-015-0498-7. Epub 2015 Dec 10. Review.

19.

Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.

Kobayashi H, Matsuda Y, Hitomi T, Okuda H, Shioi H, Matsuda T, Imai H, Sone M, Taura D, Harada KH, Habu T, Takagi Y, Miyamoto S, Koizumi A.

J Am Heart Assoc. 2015 Jun 30;4(7). pii: e002146. doi: 10.1161/JAHA.115.002146.

20.

RNF213 rare variants in an ethnically diverse population with Moyamoya disease.

Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RL, Leal SM, Wang GT, Regalado ES, Steinberg GK, Shendure J, Bamshad MJ; University of Washington Center for Mendelian Genomics, Grotta JC, Nickerson DA, Pannu H, Milewicz DM.

Stroke. 2014 Nov;45(11):3200-7. doi: 10.1161/STROKEAHA.114.006244. Epub 2014 Oct 2.

Supplemental Content

Support Center